CoChat

3-D retina organoids: Building platforms for therapies of the future

Open access
Mazerik, Jessica N, Becker, Steven, Sieving, Paul A · 2018 · Cell Medicine

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Across scientific disciplines, 3-D organoid culture systems offer platforms to integrate basic research findings with clinical care. The National Eye Institute mounted a $1.1 million 3-D Retina Organoid Challenge. Organoids developed through the Challenge will be valuable resources for drug screening, disease modeling, and precision and regenerative medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2155179018773758

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Basic research programs will continue to support technology generation, discovery, and translation in the regenerative medicine space. Scientific advances coming out of programs like the NEI Audacious Goals Initiative, the NEI 3-D Retina Organoid Challenge, and NCATS Tissue Chip programs will lay the foundation for translation of cell therapies into clinical trials such as those supported by the California Institute of Regenerative Medicine (CIRM) and the National Institutes of Health (NIH). NAM: National Academy of Medicine.
Figure 1. Basic research programs will continue to support technology generation, discovery, and translation in the regenerative medicine space. Scientific advances coming out of programs like the NEI Audacious Goals Initiative, the NEI 3-D Retina Organoid Challenge, and NCATS Tissue Chip programs will lay the foundation for translation of cell therapies into clinical trials such as those supported by the California Institute of Regenerative Medicine (CIRM) and the National Institutes of Health (NIH). NAM: National Academy of Medicine.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 16

Metadata

Authors
Mazerik, J. N., Becker, S., & Sieving, P. A.
Affiliations
National Institutes of Health (US)
Corresponding author
Becker, Steven
Venue
Cell Medicine
Published
2018-01-01
Volume
10
Pages
2155179018773758-2155179018773758
ISSN
2155-1790 (ISSN-L)
OpenAlex
W2805799337
Cited by
12
References
27
Citations by year
2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Cell Medicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
drug screening, disease modeling, precision medicine, regenerative medicine, retinal tissue engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 3-D retina organoids: Building platforms for therapies of the future. https://app.cochat.ai/papers/10.1177/2155179018773758
The paper
Mazerik, J. N., Becker, S., & Sieving, P. A. (2018). 3-D retina organoids: Building platforms for therapies of the future. Cell Medicine. https://doi.org/10.1177/2155179018773758

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.